FOLEY & LARDNER LLP

Lobbying for ENDO USA, INC., A MALLINCKRODT-ENDO COMPANY · pharmaceutical manufacturing

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Pennsylvania · House · Senate · $70,000.00 income · posted Jul 8, 2025

Lobbying activity 2

Pharmacy

Issues related to Domestic manufacturing; Issues related to 340B; implementation of the Inflation Reduction Act; Issues related to supply chain resilience; Issues related to trade policy.

Health Issues

Issues related to Domestic manufacturing; Issues related to 340B; implementation of the Inflation Reduction Act; Issues related to supply chain resilience; Issues related to trade policy.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.